Brett Swansiger

Company: ANGLE Europe Limited

Job title: Chief Commercial Officer

Seminars:

Journey of a DDR Patient Sample: De-risking Preclinical and Clinical Research 12:30 pm

Advanced CTC isolation with Parsortix® FDA-510k cleared capture technology Integration of CTCs with known DDR biomarker assays Provide strategies to minimize risks in the development of targeted DDR therapies Explore future approaches to evaluate DDR inhibitors based upon responses guided by Parsortix enriched CTCsRead more

day: Day One Track B AM